ArticleAging cell2026
Protein Tyrosine Phosphatase 1B-Mediated Granulosa Cell Insulin Resistance Links Metabolic Stress to Aging-Relevant Ovarian Dysfunction and Is Reversed by Gengnianchun.
Article in Aging cell, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Metabolic disorders, particularly insulin resistance, are increasingly recognized as accelerators of female reproductive decline. However, the molecular mechanisms by which peripheral metabolic stress translates into impaired ovarian reserve remain incompletely understood. Here, we propose that protein tyrosine phosphatase 1B (PTP1B), a negative regulator of insulin signaling, serves as a molecular bridge linking systemic insulin resistance to aging-relevant ovarian dysfunction and can be pharmacologically targeted. By integrating transcriptomic profiling of granulosa cells from women with diminished ovarian reserve (DOR) with network-based pharmacology and IR-DOR-associated gene annotations, we identified PTP1B as a candidate mediator of a metabolic stress-associated ovarian dysfunction axis. In a high-fat diet (HFD)-induced mouse model of systemic insulin resistance and metabolic stress-associated ovarian dysfunction, treatment with the traditional multi-herbal formula Gengnianchun (GNC) improved systemic glucose homeostasis, restored estrous cyclicity, and preserved primordial and growing follicles. These effects were accompanied by reduced ovarian PTP1B expression, reactivation of IRS1-AKT2 signaling, and enhanced GLUT4-mediated glucose handling in granulosa cells. In human granulosa-like KGN cells, GNC selectively restored insulin signaling and cell migration under insulin-resistant conditions; these effects were phenocopied by PTP1B knockdown and attenuated by PTP1B overexpression or pharmacological inhibition of AKT2. Collectively, these findings identify ovarian PTP1B as a key mediator of metabolic stress-associated, aging-relevant ovarian dysfunction and highlight PTP1B-directed interventions, including GNC, as potential strategies to preserve ovarian function in metabolically vulnerable states.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.